Skip to main content

Registration
IDWeek Learning Objective
Return to Sessions
and Exhibits
Chasing the Sun
Schedule
Speakers
Oral Abstracts
Posters
Featured Speakers
FAQ

IDWeek 2020 Main banner

Registration
IDWeek Learning Objective
Return to Sessions
and Exhibits
Chasing the Sun
Schedule
Speakers
Oral Abstracts
Posters
Featured Speakers
FAQ

Tweets by IDWeek 2020

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Chasing the Sun

Live

On Demand

Back

Favorite
0 Like
Facebook
Tweet
Print

Kai S. Hove, MRes

Clinical Study Manager
GlaxoSmithKline

Disclosure: GSK (Independent Contractor)

Presentation(s):

LB-8 - Summary of COVID-Related Impact on Cabotegravir and Rilpivirine Long-Acting (CAB+RPV LA) Dosing Across the Six Ongoing Global Phase IIb and IIIb Clinical Trials
Saturday, October 24, 2020
11:00am – 11:10am EDT

Designed by CadmiumCD |Technical Support |Give Feedback
© Copyright 2024 CadmiumCD. All Rights Reserved.